Johnson Investment Counsel Inc Inogen Inc Transaction History

Johnson Investment Counsel Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$41.82 - $66.71 $155,277 - $247,694	-3,713 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$63.19 - $95.15 $2.63 Million - $3.97 Million	-41,677 Reduced 91.82%	3,713 $247,000
Q1 2019 May 13, 2019	BUY	$90.12 - $152.23 $394,725 - $666,767	4,380 Added 10.68%	45,390 $4.33 Million
Q4 2018 Feb 13, 2019	BUY	$112.83 - $239.74 $1.07 Million - $2.28 Million	9,505 Added 30.17%	41,010 $5.09 Million
Q3 2018 Nov 14, 2018	SELL	$189.1 - $282.92 $139,555 - $208,794	-738 Reduced 2.29%	31,505 $7.69 Million
Q2 2018 Aug 14, 2018	SELL	$123.8 - $192.48 $846,173 - $1.32 Million	-6,835 Reduced 17.49%	32,243 $6.01 Million
Q1 2018 May 15, 2018	BUY	$114.22 - $133.22 $4.46 Million - $5.21 Million	39,078 New	39,078 $4.8 Million

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $220M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Johnson Investment Counsel Inc with notifications on news.